PRMT5 and oral cavity squamous cell carcinoma: We previously observed that the expression of NDRG2 was low in many types of solid cancers, including SAS (oral squamous cell carcinoma) and U2OS (osteosarcoma), and cell proliferation was significantly suppressed by silencing PRMT5 expression with the degradation of AKT and NEMO proteins [10].